Zealand Pharma Shares Plunge 25% After Safety Data Raises Concerns Over Experimental Weight Loss Drug
Shares of Danish drugmaker Zealand Pharma dropped as much as 26% after new safety data on its experimental obesity medicine raised investor concerns over potential side effects.
·1 source
